GoodRx Holdings (GDRX) Gross Profit (2019 - 2026)

GoodRx Holdings (GDRX) has 8 years of Gross Profit data on file, last reported at $173.8 million in Q1 2026.

• For the quarter ending Q1 2026, Gross Profit fell 8.31% year-over-year to $173.8 million; the trailing twelve-month figure through Mar 2026 stood at $723.5 million (down 3.31% YoY), and the FY2025 full-year result was $739.3 million, down 0.65% from the prior year.
• Gross Profit retreated to $173.8 million in Q1 2026, from $177.3 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $191.0 million in Q1 2022 to a low of $161.2 million in Q3 2023.
• A 5-year average of $178.9 million and a median of $181.5 million in 2023 frame the typical range for Gross Profit.
• Peak annual rise in Gross Profit reached 27.36% in 2022, while the deepest fall reached 16.34% in 2022.
• Tracing GDRX's Gross Profit over 5 years: stood at $166.7 million in 2022, then grew by 8.83% to $181.5 million in 2023, then increased by 2.71% to $186.4 million in 2024, then fell by 4.87% to $177.3 million in 2025, then slipped by 1.96% to $173.8 million in 2026.
• Business Quant data shows GDRX's Gross Profit at $173.8 million in Q1 2026, $177.3 million in Q4 2025, and $182.6 million in Q3 2025.